# Oricell funding rounds and investors

As of 14 Oct 2026, Oricell has raised $110M across 1 verified round on record; latest: $110 million growth round led by Beijing Medical and Health Care Industry Investment Fund, Qiming Venture Partners and 1 other, announced 9 Apr 2026.

Oricell develops cell therapies specifically aimed at treating cancer patients, particularly through advanced CAR-T technology.

Website: https://oricell.com  
Headquarters: Shanghai, China  
Page: https://fireround.dev/companies/oricell.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-04-09 | Growth | $110 million | Beijing Medical and Health Care Industry Investment Fund, Qiming Venture Partners, Vivo Capital | E-Town Capital, Luxin Venture Capital, NGS Super | [fiercebiotech.com](https://www.fiercebiotech.com/biotech/chinas-oricell-raises-100m-carcinoma-car-t-plans-ahead-ipo-push) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.